Stay updated on NICHE: Clinical Trial on IO in Early Colon Cancer
Sign up to get notified when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.

Latest updates to the NICHE: Clinical Trial on IO in Early Colon Cancer page
- CheckyesterdayChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAccrual for cohort 8 was reached in February 2026. As of February 2026, only cohorts 5 and 7 remain open for recruitment, and patients with dMMR/MSI tumors will be automatically registered in cohort 7 to receive nivolumab + relatlimab.SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. This represents a minor version update with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 to reflect the latest site update.SummaryDifference0.0%

- Check59 days agoChange DetectedIn the Study Record Dates section, the label 'Last Update Posted' was added and the label 'Last Update Posted (Estimated)' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedMinor site revision labels were updated from v3.3.3 to v3.3.4 on the NICHE ClinicalTrials.gov page; no study details, eligibility criteria, or scheduling information appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to NICHE: Clinical Trial on IO in Early Colon Cancer
Enter your email address, and we'll notify you when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.